TUBERCULOSIS

Recommendations

Info

:: Box 3.2 Updates to estimates of TB disease burden in this report and anticipated updates and unit costs estimates from WHO- CHOICE. In a few cases, there were large discrepancies (e.g. Cambodia, the Philippines and the United Republic of Tanzania). Further discussions with country focal points for national health account data are needed in order to better understand the reasons for these discrepancies. Expanded implementation of SHA and associated validation against existing disease-specific tracking systems may also facilitate more comprehensive reporting of domestic funding for TB, especially reporting of the contributions from subnational administrative levels that are not always known or compiled at the national level. Although much of this contribution is likely to be for delivery of inpatient and outpatient care (which is included in current WHO estimates of domestic funding for TB, as explained above), reporting of funding from these levels (including TB-specific budgets) is a particular challenge in large countries with decentralized systems. Examples for TB include Indonesia, Nigeria and South Africa. :: TABLE B7.1.1 Methods used to review and validate financing data reported by NTPs, 30 high TB burden countries COUNTRY UNIT COST DATA AVAILABLE FROM INDEPENDENT ECONOMIC EVALUATION TRIANGULATION OF WHO TB DATA WITH OTHER SOURCES NATIONAL HEALTH ACCOUNT DATA, FOR COMPARISON OF INPATIENT AND OUTPATIENT CARE EXPENDITURES FOR DRUG- SUSCEPTIBLE AND MDR-TB COSTED NATIONAL STRATEGIC PLAN SUBMITTED AS PART OF A FUNDING APPLICATION TO THE GLOBAL FUND Angola no no no Bangladesh yes no yes Brazil yes no no Cambodia yes yes, 2012 yes Central African Republic no no no China yes no no Congo no no no DPR Korea no no no DR Congo no yes, 2014 yes Ethiopia yes no yes India yes no yes Indonesia yes no yes Kenya yes no no Lesotho no no no Liberia no no no a Floyd K, Pantoja A, Dye C. Financing tuberculosis control: the role of a global financial monitoring system. Bull World Health Organ. 2007;85(5):334-340 (http:// www.ncbi.nlm.nih.gov/pubmed/17639216, accessed 29 July 2016). Mozambique Myanmar Namibia Nigeria no no no yes no no yes, 2012 no yes yes no no b Floyd K, Fitzpatrick C, Pantoja A, Raviglione M. Domestic and donor financing for tuberculosis care and control in low-income and middleincome countries: an analysis of trends, 2002–11, and requirements to meet 2015 targets. Lancet Glob Health. 2013;1(2):e105– 115 (http://www.ncbi.nlm.nih.gov/ pubmed/25104145, accessed 28 July 2016). c Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics. 2015;33(9):939- 955 (http://www.ncbi.nlm.nih.gov/ pubmed/25939501, accessed 29 July 2016). d Global Fund Data and the Open Data Protocol http://web-api.theglobalfund.org/odata/, accessed May 2016 and country financial gap analysis materials approved for funding in the first rounds of New Funding Model. Pakistan Papua New Guinea Philippines Russian Federation Sierra Leone South Africa UR Tanzania Thailand Viet Nam Zambia Zimbabwe yes no yes yes yes yes yes yes yes yes yes no no yes, 2012 no yes, 2013 no yes, 2012 no no no no yes no yes no no no yes yes yes yes yes e Cost effectiveness and strategic planning (WHO-CHOICE): health service delivery costs. Geneva: World Health Organization; 2008 (http://www. who.int/choice/cost-effectiveness/inputs/health_service/en/, accessed 29 July 2016). f OECD/Eurostat/WHO. A system of health accounts. OECD Publishing; 2011 (http://www.who.int/health-accounts/methodology/sha2011.pdf, accessed 29 July 2016). g Health accounts. Geneva: World Health Organization (http://www.who. int/health-accounts/en/, accessed 29 July 2016). GLOBAL <strong>TUBERCULOSIS</strong> REPORT 2016 :: 113
:: TABLE 7.2 Reported NTP budget by intervention area and estimated cost of inpatient and outpatient care for drug-susceptible (DS-TB) and MDR-TB, 30 high TB burden countries, 2016 (current US$ millions) NATIONAL STRATEGIC PLAN BUDGET RESOURCES REQUIRED FOR INPATIENT AND OUTPATIENT CARE a TOTAL DS-TB MDR-TB TB/HIV DS-TB MDR-TB RESOURCES REQUIRED FOR TB CARE a Angola 22 19 2.0 0.41 12 3.0 36 Bangladesh 52 49 2.3 0.11 1.5 0.2 54 Brazil 60 48 11 2.0 37 1.8 99 Cambodia 29 26 1.9 0.61 24 0.4 53 Central African Republic 1.8 1.4 0.06 0.35 0.63 0.04 2.5 China 372 348 24 0 — — 372 Congo 3.8 2.1 1.6 0.07 0.10 0 3.9 DPR Korea 30 27 3.3 0.05 41 0.82 72 DR Congo 60 51 5.7 3.6 17 0 77 Ethiopia 81 54 17 9.3 9.9 0.29 91 India 280 209 65 5.6 456 76 811 Indonesia 123 101 15 6.2 29 6.2 158 Kenya 59 45 0.86 12.6 4.3 0.7 64 Lesotho 6.4 5.3 1.0 0.12 0.30 0.11 6.8 Liberia 1.3 0.89 0.26 0.15 32 0 34 Mozambique 24 16 2.9 4.9 3.4 0.13 27 Myanmar 69 51 16 1.9 5.8 0.44 75 Namibia 38 30 1.3 6.7 5.0 9.1 53 Nigeria 257 171 74 13 8.8 2.6 268 Pakistan 62 43 19 0.12 6.6 0.19 69 Papua New Guinea 11 7.8 3.0 0.48 3.3 0.47 15 Philippines 104 68 36 0.40 82 7.0 194 Russian Federation b 1 385 766 583 37 — — 1 385 Sierra Leone 10 7.6 0.87 1.5 17 0 27 South Africa 425 276 68 81 92 387 905 Thailand 31 27 3.8 0.13 7.0 0.23 38 UR Tanzania 40 35 2.8 2.1 40 4.9 84 Viet Nam 71 55 14 3.0 28 3.9 103 Zambia 11 9.0 0.58 1.1 2.0 0.61 13 Zimbabwe 28 23 1.1 3.9 0.50 0.05 28 30 high TB burden countries 3747 2573 977 198 966 506 5219 Blank cells indicate data not reported. — indicates values that cannot be calculated. a No amount is shown for China and the Russian Federation because the NTP budgets reported by those countries include all budgets for inpatient and outpatient care. b In the Russian Federation, the staff and infrastructure reported for TB care and control were allocated to DS-TB (54%) and MDR-TB (46%) by WHO based on the proportion of beddays used by DS-TB and MDR-TB patients. 114 :: GLOBAL <strong>TUBERCULOSIS</strong> REPORT 2016
Page 1 and 2:
GLOBAL REPORT TUBERCULOSIS 2016
Page 3 and 4:
WHO Library Cataloguing-in-Publicat
Page 5 and 6:
:: Abbreviations aDSM AE AIDS ART A
Page 7 and 8:
The principal source of financial s
Page 9:
Zhumagali Ismailov, Sarah Jackson,
Page 12 and 13:
:: Executive Summary Background The
Page 14 and 15:
TB prevention services South Africa
Page 16 and 17:
Chapter 1 :: Introduction Tuberculo
Page 18 and 19:
:: Box 2.1 The Sustainable Developm
Page 20 and 21:
:: Box 2.3 The End TB Strategy at a
Page 22 and 23:
:: TABLE 2.1 Top 10 indicators (not
Page 24 and 25:
TABLE 2.2 :: The three TB high-burd
Page 26 and 27:
Chapter 3 :: TB disease burden :: K
Page 28 and 29:
:: Box 3.1 The WHO Global Task Forc
Page 30 and 31:
:: Box 3.2 Updates to estimates of
Page 32 and 33:
:: Box 3.3 Updated and interim esti
Page 34 and 35:
:: FIG. 3.1 Strengthening national
Page 36 and 37:
:: TABLE 3.2 Estimated epidemiologi
Page 38 and 39:
:: FIG. 3.3 Estimated TB incidence
Page 40 and 41:
:: FIG. 3.5 Global trends in the es
Page 42 and 43:
:: FIG. 3.8 Trends in estimated TB
Page 44 and 45:
:: FIG. 3.10a Top causes of death w
Page 46 and 47:
:: FIG. 3.14 Trends in estimated TB
Page 48 and 49:
:: FIG. 3.16 Data sources available
Page 50 and 51:
:: TABLE 3.5 Estimated incidence of
Page 52 and 53:
:: FIG. 3.20 Estimated incidence of
Page 54 and 55:
:: FIG. 3.22 Global progress in imp
Page 56 and 57:
:: TABLE 3.6 Number of TB cases fou
Page 58 and 59:
:: TABLE 3.7 HIV-negative and HIV-p
Page 60 and 61:
:: FIG. 3.29a The prevalence:notifi
Page 62 and 63:
:: FIG. 3.31b The average CFR by st
Page 64 and 65:
SIM and SINAN case-based databases,
Page 66 and 67:
Prompt and accurate diagnosis of tu
Page 68 and 69:
:: FIG. 4.2 New and relapse TB case
Page 70 and 71:
:: FIG. 4.5 Percentage of new and r
Page 72 and 73:
:: FIG. 4.8 Global numbers of notif
Page 74 and 75: :: TABLE 4.4 National guidance in p
Page 76 and 77: :: FIG. 4.9 Percentage of bacteriol
Page 78 and 79: :: FIG. 4.12 Number of MDR/RR-TB ca
Page 80 and 81: :: FIG. 4.14 Case notification rate
Page 82 and 83: :: FIG. 4.16a The ten countries wit
Page 84 and 85: :: Box 4.5 Community contributions
Page 86 and 87: :: FIG. 4.18 Estimated ART treatmen
Page 88 and 89: issued in March 2013 and updated in
Page 90 and 91: :: FIG. 4.22 Treatment outcomes for
Page 92 and 93: :: Box 4.6 Active TB drug-safety mo
Page 94 and 95: Prevention of new infections of Myc
Page 96 and 97: :: TABLE 5.2 TB preventive treatmen
Page 98 and 99: :: TABLE 5.3 Provision of TB preven
Page 100 and 101: :: FIG. 5.5 Coverage of BCG vaccina
Page 102 and 103: This chapter aims to provide a tube
Page 104 and 105: :: FIG. 6.2 Government spending on
Page 106 and 107: :: Box 6.1 Implications for TB of e
Page 108 and 109: :: Box 6.2 Innovations in engaging
Page 110 and 111: :: Box 6.4 Reforming systems to exp
Page 112 and 113: :: TABLE 6.1 TB patient social supp
Page 114 and 115: :: FIG. 6.5 Surveys of costs faced
Page 116 and 117: :: TABLE 6.3 Status of selected SDG
Page 118 and 119: Continue current trend (base case s
Page 120 and 121: can provide insights into progress
Page 122 and 123: lion, most (US$ 4.4 billion, 67%) i
Page 126 and 127: :: FIG. 7.5 Funding for NTP budgets
Page 128 and 129: :: Box 7.2 International donor fund
Page 130 and 131: :: FIG. 7.6 Reported funding gaps f
Page 132 and 133: :: Box 7.3 Methods used to estimate
Page 134 and 135: :: Box 8.1 WHO’s Global Action Fr
Page 136 and 137: is critical to allow for the time-s
Page 138 and 139: :: FIG. 8.2 The global development
Page 140 and 141: :: FIG. 8.3 The development pipelin
Page 142: Annex 1 Access to the WHO global TB
Page 145 and 146: A data dictionary that defines each
Page 147: Annex 2 Country profiles :: FOR 30
Page 150 and 151: Bangladesh population 2015 :: 161 m
Page 152 and 153: China population 2015 :: 1 376 mill
Page 154 and 155: Democratic Republic of the Congo po
Page 156 and 157: India population 2015 :: 1 311 mill
Page 158 and 159: Kenya population 2015 :: 46 million
Page 160 and 161: Myanmar population 2015 :: 54 milli
Page 162 and 163: Pakistan population 2015 :: 189 mil
Page 164 and 165: Russian Federation population 2015
Page 166 and 167: Thailand population 2015 :: 68 mill
Page 168: Viet Nam population 2015 :: 93 mill
Page 171 and 172: Central African Republic population
Page 173 and 174: Lesotho population 2015 :: 2.1 mill
Page 175 and 176:
Namibia population 2015 :: 2.5 mill
Page 177 and 178:
Sierra Leone population 2015 :: 6.5
Page 179 and 180:
Zimbabwe population 2015 :: 16 mill
Page 182 and 183:
WHO African Region WHO MEMBER STATE
Page 184 and 185:
WHO Eastern Mediterranean Region WH
Page 186 and 187:
WHO South-East Asia Region WHO MEMB
Page 188:
Annex 4 TB burden estimates, notifi
Page 191 and 192:
:: TABLE A4.1 TB incidence estimate
Page 193 and 194:
:: TABLE A4.1 Table TB incidence A4
Page 195 and 196:
:: Table TABLE A4.2 A4.2 Estimates
Page 197 and 198:
Table :: TABLE A4.2 A4.2 Estimates
Page 199 and 200:
:: TABLE A4.3 Measured percentage o
Page 201 and 202:
:: TABLE A4.3 Measured Table A4.3 p
Page 203 and 204:
:: TABLE A4.4 TB case notifications
Page 205 and 206:
:: TABLE A4.4 TB case notifications
Page 207 and 208:
:: TABLE A4.5 Treatment outcomes by
Page 209 and 210:
:: TABLE A4.5 Treatment outcomes by
Page 211:
ISBN 9 789241 565394 Ending TB by 2
show all

TUBERCULOSIS

Create successful ePaper yourself

Delete template?

Save as template?